Status and phase
Conditions
Treatments
About
The purpose of the study was to contribute, along with other such dose-finding studies, to the identification of the most effective treatment regimen for a one month depot injection of degarelix in the treatment of prostate cancer by a rapid and sustained suppression of testosterone.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Each patient must meet the following inclusion criteria before entry into the study.
Exclusion criteria
Any patient meeting one or more of the following exclusion criteria will not be entered into the study.
Primary purpose
Allocation
Interventional model
Masking
127 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal